Sunday, November 8, 2026

EUR/CHF Is 2% Up In The Last 10 Sessions

EUR/CHF Is 2% Up In The Last 10 Sessions

(VIANEWS) - EUR/CHF (EURCHF) has been up by 2.02% for the last 10 sessions. At 08:06 EST on Tuesday, 2 July, EUR/CHF (EURCHF) is $0.97.

EUR/CHF's yearly highs and lows, it's 7.364% up from its 52-week low and 2.367% down from its 52-week high.

Volatility

EUR/CHF's last week, last month's, and last quarter's current intraday variation average was a positive 0.22%, a negative 0.05%, and a positive 0.24%, respectively.

EUR/CHF's highest amplitude of average volatility was 0.25% (last week), 0.27% (last month), and 0.24% (last quarter), respectively.

Forex Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, EUR/CHF's Forex is considered to be oversold (<=20).

News about

  • According to FXStreet on Tuesday, 2 July, "At the time of writing, EUR/USD is dropping 0.18% on the day to trade near 1.0720."
  • Eur/usd gets rid of some political risk premium – ING. According to FXStreet on Monday, 1 July, "We think this week's US data can push EUR/USD higher, but French politics can still put a cap on the pair this summer, ING FX strategist Francesco Pesole notes.", "It appears that EUR/USD is getting rid of some political risk premium this morning after preliminary results from the first round of French parliamentary elections came in close to pre-vote polls. "
  • Eur/usd price analysis: hovers around 1.0750 within the consolidative range. According to FXStreet on Tuesday, 2 July, "The 14-day Relative Strength Index (RSI) remains slightly below the 50 level, suggesting the EUR/USD pair trading within a consolidative range between 1.0780-1.0670. ", "On the upside, the EUR/USD pair may encounter resistance at the 50-day Exponential Moving Average (EMA) situated at 1.0769. "

More news about EUR/CHF (EURCHF).

In this story · Knowledge Files

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biotech Catalyst Season: Regulatory Deadlines and Data Readouts Against Cost Discipline and Slipping Timelines
From late October 2026 to January 2027, mid-cap biotechs cluster pivotal data presentations (ESMO, AHA, AASLD), FDA decision dates (ivonescimab BLA on 2026-11-14, lorundrostat on 2026-12-22) and Q3 earnings. Alongside these, several companies are managing capital: lowering R&D and SG&A guidance, pushing clinical milestones into 2027, authorizing a $400M buyback, and pursuing a delisting. Late-stage programs in oncology, hepatitis delta, hypertension and women's health look near commercial inflection, while cost cuts and delays point to uneven balance-sheet strength.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,996
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,996 facts checked against source5,552 source documents archived
Query this data → isubstrate.com